- Country: Guatemala
- Summary: Benralizumab 30 mg/ml injectable solution of the Fasenra brand, according to Amparo 01022-2024-00154 - IGSS code 77135 - page 2730/2025
- GTT Ref No: 126733469
- Deadline: 23 Sep 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 27902579
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Tenders are invited for Benralizumab 30 mg/ml injectable solution of the Fasenra brand, according to Amparo 01022-2024-00154 - IGSS code 77135 - page 2730/2025
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINBenralizumab 30 mg/ml injectable solution of the Fasenra brand, according to Amparo 01022-2024-00154 - IGSS code 77135 - page 2730/2025 - Guatemala Tender
The GUATEMALAN SOCIAL SECURITY INSTITUTE -IGSS-, a Government sector organization in Guatemala, has announced a new tender for Benralizumab 30 mg/ml injectable solution of the Fasenra brand, according to Amparo 01022-2024-00154 - IGSS code 77135 - page 2730/2025. This tender is published on GuatemalaTenders under GTT Ref No: 126733469 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-09-23.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
